173 related articles for article (PubMed ID: 20613899)
1. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.
Salman MC; Usubutun A; Boynukalin K; Yuce K
J Gynecol Oncol; 2010 Jun; 21(2):97-101. PubMed ID: 20613899
[TBL] [Abstract][Full Text] [Related]
2. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
3. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
Histopathology; 2019 Apr; 74(5):676-687. PubMed ID: 30347477
[TBL] [Abstract][Full Text] [Related]
4. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
[TBL] [Abstract][Full Text] [Related]
5. Comparison of endometrial cancer risk in patients with endometrial precancerous lesions: WHO 1994 vs EIN classification.
Kender Erturk N; Basaran D; Salman C
J Obstet Gynaecol; 2022 May; 42(4):692-695. PubMed ID: 34415826
[TBL] [Abstract][Full Text] [Related]
6. New classification system of endometrial hyperplasia WHO 2014 and its clinical implications.
Sobczuk K; Sobczuk A
Prz Menopauzalny; 2017 Sep; 16(3):107-111. PubMed ID: 29507578
[TBL] [Abstract][Full Text] [Related]
7. Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 May; 299(5):1233-1242. PubMed ID: 30810881
[TBL] [Abstract][Full Text] [Related]
8. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system.
Baak JP; Mutter GL; Robboy S; van Diest PJ; Uyterlinde AM; Orbo A; Palazzo J; Fiane B; Løvslett K; Burger C; Voorhorst F; Verheijen RH
Cancer; 2005 Jun; 103(11):2304-12. PubMed ID: 15856484
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network.
Zhao F; Dong D; Du H; Guo Y; Su X; Wang Z; Xie X; Wang M; Zhang H; Cao X; He X
Comput Methods Programs Biomed; 2022 Jun; 221():106906. PubMed ID: 35671602
[TBL] [Abstract][Full Text] [Related]
10. Congruence Between 1994 WHO Classification of Endometrial Hyperplasia and Endometrial Intraepithelial Neoplasia System.
Travaglino A; Raffone A; Saccone G; Mascolo M; Guida M; Mollo A; Insabato L; Zullo F
Am J Clin Pathol; 2020 Jan; 153(1):40-48. PubMed ID: 31433834
[TBL] [Abstract][Full Text] [Related]
11. Endometrial Intraepithelial Neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 World Health Organization classification for endometrial hyperplasia.
Li XC; Song WJ
Asian Pac J Cancer Prev; 2013; 14(10):5935-9. PubMed ID: 24289604
[TBL] [Abstract][Full Text] [Related]
12. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
13. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; D'Alessandro P; Arduino B; de Placido G; Mascolo M; Insabato L; Zullo F
Arch Gynecol Obstet; 2019 Nov; 300(5):1147-1154. PubMed ID: 31531779
[TBL] [Abstract][Full Text] [Related]
14. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
[TBL] [Abstract][Full Text] [Related]
15. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
[TBL] [Abstract][Full Text] [Related]
16. Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysis.
Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1415-1426. PubMed ID: 30168854
[TBL] [Abstract][Full Text] [Related]
17. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Mascolo M; Insabato L; Zullo F
APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
[TBL] [Abstract][Full Text] [Related]
18. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis.
Hecht JL; Ince TA; Baak JP; Baker HE; Ogden MW; Mutter GL
Mod Pathol; 2005 Mar; 18(3):324-30. PubMed ID: 15529181
[TBL] [Abstract][Full Text] [Related]
19. Endometrial hyperplasia as a risk factor of endometrial cancer.
Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
[TBL] [Abstract][Full Text] [Related]
20. Incidence of endometrial carcinoma in patients with endometrial intraepithelial neoplasia versus atypical endometrial polyp.
Cohen A; Tsur Y; Tako E; Levin I; Gil Y; Michaan N; Grisaru D; Laskov I
Int J Gynecol Cancer; 2022 Dec; ():. PubMed ID: 36600505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]